mRNA,ESKAPE

Saber Imani1, Shuojie Lv1, Hongbo Qian1

  • 1Key Laboratory of Artificial Organs and Computational Medicine of Zhejiang Province, Key Laboratory of Pollution Exposure and Health Intervention of Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University, Hangzhou 310015, Zhejiang, China.

Biotechnology advances
|December 5, 2024
PubMed
概括

使者RNA (mRNA) 疫苗显示出对抗多药耐药 (MDR) ESKAPE病原体的承诺. 这种可适应的免疫疗法平台刺激抗体和T细胞的反应,以对抗这些关键的感染.